Literature DB >> 26169456

Management of Patients with Internal Carotid Artery Near-total Occlusion: An Updated Meta-analysis.

Spyridon N Mylonas1, Constantine N Antonopoulos2, Konstantinos G Moulakakis2, John D Kakisis2, Christos D Liapis2.   

Abstract

BACKGROUND: The decision for revascularization in patients with near-total internal carotid artery (ICA) occlusion still remains controversial. We undertook an extensive review of the literature and conducted a meta-analysis aiming to investigate the appropriate therapeutic approach for patients with near-total ICA occlusion.
METHODS: A multiple electronic health database search was performed on all articles published up to December 2014. All available data were analyzed giving emphasis on the applied therapeutic approach (best medical therapy [BMT], carotid endarterectomy [CEA], and carotid artery stenting [CAS]), whereas the main endpoints of the meta-analysis were transient ischemic attack (TIA), stroke, stroke-related death, myocardial infarction (MI), major adverse event (MAE), overall mortality, and restenosis.
RESULTS: Five articles on BMT and CEA, 8 articles on CEA, and 11 articles on CAS were deemed eligible. A statistically significant difference was recorded in pooled stroke incidence rates (IRs) per 100 patient-years (p-ys) of BMT (IR = 6.19) compared with CEA (IR = 2.24, P = 0.002) and CAS (IR = 1.64, P < 0.001) studies. No statistically significant differences were recorded in pooled IRs per 100 p-ys between CEA and CAS, concerning TIA (P = 0.96), stroke (P = 0.44), stroke-related death (P = 0.30), and MAE (P = 0.99), whereas a borderline significance was recorded concerning overall mortality (P = 0.08) and restenosis (P = 0.08). No nominally significant effects were demonstrated with respect to almost all the studied potential modifiers in meta-regression analysis among the eligible studies.
CONCLUSIONS: An intervention is probably indicated for patients with near-total ICA occlusion. The results of our study underline the need for including patients with near-total ICA occlusion in future randomized controlled trials. Meanwhile, the treatment of these patients should be individualized.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26169456     DOI: 10.1016/j.avsg.2015.05.015

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  7 in total

1.  Bilateral Internal Carotid Arteries Occlusion: A Case Report.

Authors:  Prabhaw Upadhyaya; Prasanna Karki; Baburam Pokharel; Gopal Raman Sharma
Journal:  JNMA J Nepal Med Assoc       Date:  2022-02-15       Impact factor: 0.556

2.  Current understanding of chronic total occlusion of the internal carotid artery.

Authors:  Baofeng Xu; Chao Li; Yunbao Guo; Kan Xu; Yi Yang; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-18

3.  Carotid endarterectomy in patients with recurrent symptoms associated with an ipsilateral carotid artery near occlusion with full collapse.

Authors:  A J A Meershoek; E P A Vonken; P J Nederkoorn; L J Kappelle; G J de Borst
Journal:  J Neurol       Date:  2018-06-18       Impact factor: 4.849

4.  Meta-analysis of the outcomes of treatment of internal carotid artery near occlusion.

Authors:  A J A Meershoek; E E de Vries; D Veen; H M den Ruijter; G J de Borst
Journal:  Br J Surg       Date:  2019-05       Impact factor: 6.939

5.  Prevention and treatment of strokes associated with carotid artery stenosis: a research priority.

Authors:  Kosmas I Paraskevas
Journal:  Ann Transl Med       Date:  2020-10

Review 6.  Management of internal carotid artery near-occlusion: the need for updated evidence.

Authors:  Constantine N Antonopoulos; Alexandros Giosdekos; Spyridon N Mylonas; Christos D Liapis
Journal:  Ann Transl Med       Date:  2020-10

7.  Bilateral Internal Carotid Artery Occlusion, an Unusual Clinical Entity in a Young Adult.

Authors:  Monika Karki; Pradeep Kumar Devarakonda; Lohitha Dhulipalla; Meghana Pattipati; Cesar Ayala-Rodriguez
Journal:  Cureus       Date:  2021-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.